MDT250117P77500
- 0.01
- 0.000.00%
Medtronic Newsroom
3 Reasons to Buy Medtronic Stock Like There's No Tomorrow
Medtronic Stock Hits 52-week High at $92.69 Amid Steady Growth
Executive Reshuffles: MDT, FI, and MASI
Here's How Many Shares of Medtronic You Need to Own to Get $1,000 in Yearly Dividends
Medtronic (MDT) Increases Despite Market Slip: Here's What You Need to Know
Medtronic Plc (MDT): Advancing AI-Powered Healthcare With Breakthrough AFib Detection Study
Medtronic Data Highlights Benefits of Closed-loop Spinal Cord Stim
Beta Bionics Sets Terms for Upsized $113M IPO
Is Medtronic Plc (MDT) the Best Stock to Invest In For Steady Dividends?
Truist Financial Maintains Medtronic(MDT.US) With Hold Rating
Truist Financial Sticks to Its Hold Rating for Medtronic (MDT)
Jim Cramer on Medtronic Plc (MDT) CEO Geoffrey S. Martha: 'I Remembered What He Said Yesterday, Which Is Things Are Pretty Darn Good'
How Much Would It Take To Earn $100 A Month From Medtronic Stock
Medtronic appoints former Renault executive as Chief Financial Officer.
Gelonghui January 21 | Medtronic announced on Tuesday the appointment of Thierry Piéton as the company's Chief Financial Officer, succeeding Gary Corona, who has been serving as the interim Chief Financial Officer. The appointment will take effect on March 3. Piéton has been the Chief Financial Officer at Renault Group since March 2022. Medtronic's former Chief Financial Officer Karen Parkhill left last June and subsequently joined HP Inc. A few months before Parkhill's departure, Medtronic decided to exit the unprofitable Business of patient monitoring and respiratory intervention (PMRI).
Medtronic Hires CFO From Renault
Medtronic: Pieton Has Been Renault Chief Financial Officer Since March 2022 >MDT
Express News | Medtronic PLC - Gary Corona to Continue as Interim CFO Until Piéton Joins
Express News | Medtronic Appoints Thierry Piéton as Chief Financial Officer
Press Release: Medtronic Appoints Thierry Piéton as Chief Financial Officer
United States Anesthesia Drugs Research Report 2025: A $3.67 Bn Market by 2033 With Competitive Analysis of Baxter, Abbvie, Medtronic, Draegerwerk, Koninklijke Philips, and Abbott Laboratories